Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
作者
Christopher L. D. McMillan,Jovin J. Y. Choo,Adi Idris,Aroon Supramaniam,Naphak Modhiran,Alberto Anastacio Amarilla,Ariel Isaacs,Stacey T. M. Cheung,Benjamin Liang,Helle Bielefeldt‐Ohmann,Armira Azuar,Dhruba Acharya,Gabrielle Kelly,Germain J. P. Fernando,Michael J. Landsberg,Alexander A. Khromykh,Daniel Watterson,Paul R. Young,Nigel A.J. McMillan,David Alexander Muller
出处
期刊:Science Advances [American Association for the Advancement of Science] 日期:2021-10-29卷期号:7 (44): eabj8065-eabj8065被引量:55
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 160 million people and resulted in more than 3.3 million deaths, and despite the availability of multiple vaccines, the world still faces many challenges with their rollout. Here, we use the high-density microarray patch (HD-MAP) to deliver a SARS-CoV-2 spike subunit vaccine directly to the skin. We show that the vaccine is thermostable on the patches, with patch delivery enhancing both cellular and antibody immune responses. Elicited antibodies potently neutralize clinically relevant isolates including the Alpha and Beta variants. Last, a single dose of HD-MAP–delivered spike provided complete protection from a lethal virus challenge in an ACE2-transgenic mouse model. Collectively, these data show that HD-MAP delivery of a SARS-CoV-2 vaccine was superior to traditional needle-and-syringe vaccination and may be a significant addition to the ongoing COVID-19 (coronavirus disease 2019) pandemic.